398 related articles for article (PubMed ID: 16608640)
21. Re-resection rates and risk characteristics following breast conserving surgery for breast cancer and carcinoma in situ: A single-centre study of 1575 consecutive cases.
Kryh CG; Pietersen CA; Rahr HB; Christensen RD; Wamberg P; Lautrup MD
Breast; 2014 Dec; 23(6):784-9. PubMed ID: 25227964
[TBL] [Abstract][Full Text] [Related]
22. The evaluation of high risk and pre-invasive breast lesions and the decision process for follow up and surgical intervention.
Simmons RM; Osborne MP
Surg Oncol; 1999 Aug; 8(2):55-65. PubMed ID: 10732957
[TBL] [Abstract][Full Text] [Related]
23. Cancer statistics: Breast cancer in situ.
Ward EM; DeSantis CE; Lin CC; Kramer JL; Jemal A; Kohler B; Brawley OW; Gansler T
CA Cancer J Clin; 2015; 65(6):481-95. PubMed ID: 26431342
[TBL] [Abstract][Full Text] [Related]
24. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ.
Simpson PT; Gale T; Fulford LG; Reis-Filho JS; Lakhani SR
Breast Cancer Res; 2003; 5(5):258-62. PubMed ID: 12927036
[TBL] [Abstract][Full Text] [Related]
25. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma.
Renshaw AA; Cartagena N; Derhagopian RP; Gould EW
Am J Clin Pathol; 2002 May; 117(5):797-9. PubMed ID: 12090431
[TBL] [Abstract][Full Text] [Related]
26. Breast surgery techniques: preoperative bracketing wire localization by surgeons.
Burkholder HC; Witherspoon LE; Burns RP; Horn JS; Biderman MD
Am Surg; 2007 Jun; 73(6):574-8; discussion 578-9. PubMed ID: 17658094
[TBL] [Abstract][Full Text] [Related]
27. Lobular carcinoma in situ and invasive lobular cancer of the breast.
Cocquyt V; Van Belle S
Curr Opin Obstet Gynecol; 2005 Feb; 17(1):55-60. PubMed ID: 15711412
[TBL] [Abstract][Full Text] [Related]
28. Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review.
Hussain M; Cunnick GH
Eur J Surg Oncol; 2011 Apr; 37(4):279-89. PubMed ID: 21306860
[TBL] [Abstract][Full Text] [Related]
29. Definition of precancerous and high-risk mammary lesions.
Bégin LR
Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
[TBL] [Abstract][Full Text] [Related]
30. Tamoxifen use in patients with ductal carcinoma in situ and T1a/b N0 invasive carcinoma.
Nakhlis F; Lazarus L; Hou N; Acharya S; Khan SA; Staradub VL; Rademaker AW; Morrow M
J Am Coll Surg; 2005 Nov; 201(5):688-94. PubMed ID: 16256910
[TBL] [Abstract][Full Text] [Related]
31. Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia?
Ibrahim N; Bessissow A; Lalonde L; Mesurolle B; Trop I; Lisbona A; El-Khoury M
AJR Am J Roentgenol; 2012 Feb; 198(2):288-91. PubMed ID: 22268170
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
Murthy V; Chamberlain RS
Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
[TBL] [Abstract][Full Text] [Related]
33. Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database.
Barry PN; Johnson RR; Harkenrider MM; Freeman AB; Kruse B; Wilson MR; Pan J; Dragun AE
Am J Med Sci; 2012 Dec; 344(6):452-6. PubMed ID: 22395715
[TBL] [Abstract][Full Text] [Related]
34. [Lobular neoplasm arising in a fibroadenoma. Clinical case report].
Leuzzi R; Barillari P; Bianco C; Caruso L; Ranieri E; Virno F
Minerva Chir; 1988 Jun; 43(12):1099-101. PubMed ID: 2845301
[No Abstract] [Full Text] [Related]
35. Clinical dilemma of ductal carcinoma in situ.
Harris JR; Morrow M
J Clin Oncol; 2009 Nov; 27(32):5303-5. PubMed ID: 19826109
[No Abstract] [Full Text] [Related]
36. Lobular carcinoma in situ: current concepts and controversies.
Schnitt SJ; Morrow M
Semin Diagn Pathol; 1999 Aug; 16(3):209-23. PubMed ID: 10490198
[TBL] [Abstract][Full Text] [Related]
37. When to do surgical resection for atypical breast lesions: Results of a prospective cohort of 518 lesions.
Cohen M; Benhaim S; Coudray AJ; Chauvet MP; Ribierre SG; Llorca FP; Faure C; Opinel P; Bertrand P; Detroyer J; Eisinger F; Lambaudie E; Dauplat MM; Charafe Jauffret E; Houvenaeghel G;
Surg Oncol; 2020 Sep; 34():80-85. PubMed ID: 32891358
[TBL] [Abstract][Full Text] [Related]
38. Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary.
Hwang H; Barke LD; Mendelson EB; Susnik B
Mod Pathol; 2008 Oct; 21(10):1208-16. PubMed ID: 18660792
[TBL] [Abstract][Full Text] [Related]
39. Carcinoma in situ of the breast.
Carter D; Smith RR
Cancer; 1977 Sep; 40(3):1189-93. PubMed ID: 198088
[TBL] [Abstract][Full Text] [Related]
40. [Surgical prevention in precancerous conditions and noninvasive cancers of the breast].
Herfarth C
Langenbecks Arch Chir; 1985; 366():513-9. PubMed ID: 2997561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
